Knockdown of circNFIX inhibits progression of glioma in vitro and in vivo by increasing miR-378e and decreasing RPN2, providing a novel mechanism for understanding the pathogenesis of glioma.
CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis.